2bPrecise https://validator.w3.org/feed/docs/rss2.html What We Do Consumer Genetic Tests Accelerate Precision Medicine for Some Providers Home 2bPrecise Joins the Epic App Orchard to Bring Its Precision Medicine Insights to the Point of Care Who We Serve InterVenn Biosciences And Aranscia Expand Commercialization Partnership For GlycoKnow™ Ovarian Cancer Diagnostic Test InterVenn Biosciences Partners With Aranscia To Accelerate Commercialization Of GlycoKnow™ Non-Invasive Ovarian Cancer Diagnostic Test DPYD Safety Update: Reducing The Risk Of Critical Or Fatal Chemotherapy Side Effects Dr. Joel Diamond Featured on Healthcare de Jure Podcast 2bPrecise Exhibiting at PMWC 2025 Spartanburg Regional Healthcare System (SRHS) Deploys 2bPrecise Enterprise 404 Error Spectral Join the Team Contact Neurogen Biomarking Announces Partnership with Aranscia Astralis US Orthopedic Alliance Selects 2bPrecise To Accelerate Precision Medicine Program Nexora Privacy Policy News & Events 2bPrecise Attending and Exhibiting at ViVE 2024 ViVE 2022 HIMSS 2022 PMWC International Cancer Screening Leaps Forward Righting Wrongs in Precision Oncology Today: Incorporating Informatics to Avoid Missed Opportunities 2bPrecise Education Series – “Precision Medicine: Your Secret to Competitive Excellence” ViVE 2024 Sign-Up Luminara PGx Biomarker Testing: Covered Soon for All Californians 2bPrecise Attending and Exhibiting at ViVE 2023 AccessDX Holdings acquires 2bPrecise Hendrick Health Deploys 2bPrecise™ Precision Health™ Platform 2bPrecise Enhancements Deliver Deeper Oncology, Medication Safety Insights for Providers 2bPrecise Releases V3.0 With Advanced Precision Oncology, Germline and Pharmacogenomic Capabilities Vidence and 2bPrecise Announce Strategic Partnership to Unleash the Power of Genomic Data in Precision Oncology 2bPrecise Deepens Oncology Functionality, Introduces Automation to Identify Medication Safety Risk in Polypharmacy Patients 2bPrecise Wins Second Consecutive “Best Overall Genomics Solution” Award in Annual MedTech Breakthrough Awards Program Handelsman Family Practice Implements 2bPrecise™ Pharmacogenomics 2bPrecise wins industry innovation award San Francisco Otolaryngology Selects 2bPrecise 2bPrecise and Murfreesboro Medical Clinic and SurgiCenter to Present at AMIA 2021 Clinical Informatics Conference on Pharmacogenomics Top 8 Precision Medicine Companies in the USA Telegenetics helps independents thrive in COVID-fueled environment KidsX Webinar Recording: Oh, Baby – Leveraging Precision Medicine at the Point of Care in Pediatrics and Neonatology Clinical Use Cases: Pharmacogenomic Results Within the EHR Workflow About 2bPrecise 2bPrecise Named “Best Overall Genomics Company” in 2023 MedTech Breakthrough Awards Program 2bPrecise Named “Best Overall Genomics Company” in 2022 MedTech Breakthrough Awards Program